Cognitive behavioral therapy for insomnia for individuals with multiple sclerosis (CALM): A randomized control trial protocol

多发性硬化 随机对照试验 医学 认知行为疗法 认知 物理疗法 失眠症 协议(科学) 认知疗法 物理医学与康复 失眠的认知行为疗法 临床试验 临床心理学 梅德林 精神科 行为疗法 试点试验
作者
Catherine F Siengsukon,Jade Robichaud,Eryen Nelson,Allison Glaser,Garrett Baber,Matthew Gratton,Anna Zanotto,Milind A. Phadnis,SHARON G. LYNCH
出处
期刊:Contemporary clinical trials communications [Elsevier BV]
卷期号:49: 101595-101595 被引量:2
标识
DOI:10.1016/j.conctc.2026.101595
摘要

Insomnia is a common problem for individuals with multiple sclerosis (MS) occurring in at least 40 % of individuals with MS. Sleep disturbances in people with MS have been associated with a reduction in cognitive performance, physical function, psychological well-being, quality of life, and occupational function, as well as increased prevalence of fatigue, pain, depression, and anxiety. Cognitive behavioral therapy for insomnia (CBT-I), a multicomponent treatment strategy, addresses thoughts and behaviors that can negatively impact sleep and is the recommended treatment for chronic insomnia. CBT-I is shown to be more effective than pharmacological interventions long-term for treating insomnia with improvements remaining up to 10 years following CBT-I. However, there are limited studies that have examined the effect of CBT-I on sleep outcomes and comorbid symptoms in people with MS. The objective of the proposed study is to determine the efficacy of CBT-I delivered via telehealth to improve insomnia symptoms, fatigue, and health-related quality of life in people with MS. CBT-I offers a low-risk, cost-effective, non-pharmacological approach to improving sleep quality, fatigue, and daily functioning in individuals with MS. Targeting insomnia in MS may also reduce disability, enhance quality of life, increase employment rates, and lower healthcare and support costs. Furthermore, understanding factors that impact improvement in outcomes will allow more accurate individualization of insomnia treatment for people with MS. Trial registration: The CALM study is registered at: https://clinicaltrials.gov (NCT06428006).
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
LIU完成签到,获得积分10
1秒前
科研通AI65的应助被fifi采纳,获得10
1秒前
Wdd完成签到,获得积分10
1秒前
风笛发布了新的文献求助10
1秒前
CBX完成签到 ,获得积分10
1秒前
fsxadada123发布了新的文献求助10
1秒前
鹿鹿发布了新的文献求助10
2秒前
2秒前
David完成签到,获得积分10
3秒前
3秒前
3秒前
优秀乐松完成签到,获得积分20
3秒前
kkk完成签到 ,获得积分10
4秒前
LUAN完成签到,获得积分10
4秒前
朵朵发布了新的文献求助10
4秒前
沓也完成签到 ,获得积分10
5秒前
5秒前
5秒前
朝暮完成签到 ,获得积分10
6秒前
木头完成签到,获得积分10
6秒前
7秒前
情怀的应助被小李采纳,获得10
7秒前
共享精神的应助被xie采纳,获得10
7秒前
lululiya完成签到,获得积分10
7秒前
Maestro_S的应助被一颗苹果采纳,获得10
7秒前
8秒前
jing完成签到 ,获得积分10
9秒前
小蘑菇的应助被安静的花卷采纳,获得10
9秒前
9秒前
木子完成签到,获得积分10
9秒前
Akim的应助被Aaron采纳,获得10
9秒前
9秒前
10秒前
10秒前
巴啦啦发布了新的文献求助10
10秒前
10秒前
jzhan142完成签到,获得积分10
10秒前
10秒前
神圣先知完成签到,获得积分10
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181155
求助须知:如何正确求助?哪些是违规求助? 9571140
关于积分的说明 21816740
捐赠科研通 7777528
什么是DOI,文献DOI怎么找? 3433436
关于科研通互助平台的介绍 2557664
邀请新用户注册赠送积分活动 2479482